Vicarious Surgical (RBOT) EBIT Growth (1y) (2021 - 2025)
Powered by 
Analysis
Vicarious Surgical (RBOT) EBIT Growth (1y) (2021 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -17.50% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 30.74% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 22.08% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 49.06% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 43.83% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 24.81% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -95.55% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 49.72% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 16.18% |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 35.21% |
| Jun 30, 2025 | 23.68% |
| Mar 31, 2025 | 2.25% |
| Dec 31, 2024 | 3.62% |
| Sep 30, 2024 | 16.85% |
| Jun 30, 2024 | 17.45% |
| Mar 31, 2024 | 27.81% |
| Dec 31, 2023 | 24.59% |
| Sep 30, 2023 | 3.65% |
| Jun 30, 2023 | -12.19% |
| Mar 31, 2023 | -22.74% |
| Dec 31, 2022 | -15.66% |
| Sep 30, 2022 | -158.87% |
| Jun 30, 2022 | -189.26% |
| Mar 31, 2022 | -247.54% |
| Dec 31, 2021 | -370.93% |
| Sep 30, 2021 | -156.24% |
| Jun 30, 2021 | -24,660.34% |